Literature DB >> 31739113

Comparative biological evaluation and G-quadruplex interaction studies of two new families of organometallic gold(I) complexes featuring N-heterocyclic carbene and alkynyl ligands.

Samuel M Meier-Menches1, Brech Aikman1, Daniel Döllerer1, Wim T Klooster2, Simon J Coles2, Nicolò Santi1, Louis Luk1, Angela Casini3, Riccardo Bonsignore4.   

Abstract

Experimental organometallic gold(I) compounds hold promise for anticancer therapy. This study reports the synthesis of two novel families of gold(I) complexes, including N1-substituted bis-N-heterocyclic carbene (NHC) complexes of general formula [Au(N1-TBM)2]BF4 (N1-TBM = N1-substituted 9-methyltheobromin-8-ylidene) and mixed gold(I) NHC-alkynyl complexes, [Au(N1-TBM)alkynyl]. The compounds were fully characterised for their structure and stability in aqueous environment and in the presence of N-acetyl cysteine by nuclear magnetic resonance (NMR) spectroscopy. The structures of bis(1-ethyl-3,7,9-trimethylxanthin-8-ylidene)gold(I), (4-ethynylpyridine)(1,9-dimethyltheobromine-8-ylidene)gold(I) and of (2,8-Diethyl-10-(4-ethynylphenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-4λ4,5λ4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinine)(1,3,7,9-tetramethylxanthin-8-ylidene)gold(I) were also confirmed by X-ray diffraction analysis. The compounds were studied for their properties as DNA G-quadruplex (G4 s) stabilizers by fluorescence resonance energy transfer (FRET) DNA melting. Only the cationic [Au(N1-TBM)2]BF4 family showed moderate G4 stabilization properties with respect to the previously reported benchmark compound [Au(9-methylcaffein-8-ylidene)2]+ (AuTMX2). However, the compounds also showed marked selectivity for binding to G4 structures with respect to duplex DNA in competition experiments. For selected complexes, the interactions with G4 s were also confirmed by circular dichroism (CD) studies. Furthermore, the gold(I) complexes were assessed for their antiproliferative effects in human cancer cells in vitro, displaying moderate activity. Of note, among the mixed gold(I) NHC-alkynyl compounds, one features a fluorescent boron-dipyrromethene (BODIPY) moiety which allowed determining its uptake into the cytoplasm of cancer cells by fluorescence microscopy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alkynyl ligands; Cancer; G-quadruplexes; Gold(I) organometallics; N-heterocyclic carbenes

Year:  2019        PMID: 31739113     DOI: 10.1016/j.jinorgbio.2019.110844

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules.

Authors:  Francesca Binacchi; Federica Guarra; Damiano Cirri; Tiziano Marzo; Alessandro Pratesi; Luigi Messori; Chiara Gabbiani; Tarita Biver
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

2.  124 I Radiolabeling of a AuIII -NHC Complex for In Vivo Biodistribution Studies.

Authors:  Federica Guarra; Alessio Terenzi; Christine Pirker; Rossana Passannante; Dina Baier; Ennio Zangrando; Vanessa Gómez-Vallejo; Tarita Biver; Chiara Gabbiani; Walter Berger; Jordi Llop; Luca Salassa
Journal:  Angew Chem Int Ed Engl       Date:  2020-07-29       Impact factor: 15.336

3.  An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells.

Authors:  Samuel M Meier-Menches; Benjamin Neuditschko; Katja Zappe; Martin Schaier; Marlene C Gerner; Klaus G Schmetterer; Giorgia Del Favero; Riccardo Bonsignore; Margit Cichna-Markl; Gunda Koellensperger; Angela Casini; Christopher Gerner
Journal:  Chemistry       Date:  2020-11-03       Impact factor: 5.236

Review 4.  Current Developments of N-Heterocyclic Carbene Au(I)/Au(III) Complexes toward Cancer Treatment.

Authors:  Alexia Tialiou; Jiamin Chin; Bernhard K Keppler; Michael R Reithofer
Journal:  Biomedicines       Date:  2022-06-15

5.  Novel Anticancer NHC*-Gold(I) Complexes Inspired by Lepidiline A.

Authors:  Danielle Curran; Helge Müller-Bunz; Sofia I Bär; Rainer Schobert; Xiangming Zhu; Matthias Tacke
Journal:  Molecules       Date:  2020-07-30       Impact factor: 4.411

6.  Comparing the Antileishmanial Activity of Gold(I) and Gold(III) Compounds in L. amazonensis and L. braziliensis in Vitro.

Authors:  Karen Minori; Letícia B Rosa; Riccardo Bonsignore; Angela Casini; Danilo C Miguel
Journal:  ChemMedChem       Date:  2020-09-28       Impact factor: 3.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.